Crystal structure of an antibody bound to an immunodominant peptide epitope: novel features in peptide-antibody recognition by Nair, Deepak T. et al.
of May 26, 2011
This information is current as
 2000;165;6949-6955J Immunol
 
Rao and Dinakar M. Salunke
Deepak T. Nair, Kavita Singh, Naresh Sahu, Kanury V. S.
 
Features in Peptide-Antibody Recognition
Immunodominant Peptide Epitope: Novel 
Crystal Structure of an Antibody Bound to an
References
 http://www.jimmunol.org/content/165/12/6949.full.html#related-urls
Article cited in: 
 
 http://www.jimmunol.org/content/165/12/6949.full.html#ref-list-1
, 7 of which can be accessed free at:cites 28 articlesThis article 
Subscriptions
 http://www.jimmunol.org/subscriptions
 is online at The Journal of ImmunologyInformation about subscribing to 
Permissions
 http://www.aai.org/ji/copyright.html
Submit copyright permission requests at
Email Alerts
 http://www.jimmunol.org/etoc/subscriptions.shtml/
Receive free email-alerts when new articles cite this article. Sign up at 
Print ISSN: 0022-1767 Online ISSN: 1550-6606.
Immunologists, Inc. All rights reserved.
by The American Association ofCopyright ©2000 
9650 Rockville Pike, Bethesda, MD 20814-3994.
The American Association of Immunologists, Inc.,
 is published twice each month byThe Journal of Immunology
 o
n
 M
ay 26, 2011
w
w
w
.jimmunol.org
D
ow
nloaded from
 
Crystal Structure of an Antibody Bound to an
Immunodominant Peptide Epitope: Novel Features in
Peptide-Antibody Recognition1
Deepak T. Nair,* Kavita Singh,* Naresh Sahu,† Kanury V. S. Rao,† and Dinakar M. Salunke2*
The crystal structure of Fab of an Ab PC283 complexed with its corresponding peptide Ag, PS1 (HQLDPAFGANSTNPD), derived
from the hepatitis B virus surface Ag was determined. The PS1 stretch Gln2P to Phe7P is present in the Ag binding site of the Ab,
while the next three residues of the peptide are raised above the binding groove. The residues Ser11P, Thr12P, and Asn13P then
loop back onto the Ag-binding site of the Ab. The last two residues, Pro14P and Asp15P, extend outside the binding site without
forming any contacts with the Ab. The PC283-PS1 complex is among the few examples where the light chain complementarity-
determining regions show more interactions than the heavy chain complementarity-determining regions, and a distal framework
residue is involved in Ag binding. As seen from the crystal structure, most of the contacts between peptide and Ab are through
the five residues, Leu3-Asp4-Pro5-Ala6-Phe7, of PS1. The paratope is predominantly hydrophobic with aromatic residues lining
the binding pocket, although a salt bridge also contributes to stabilizing the Ag-Ab interaction. The molecular surface area buried
upon PS1 binding is 756 Å2 for the peptide and 625 Å2 for the Fab, which is higher than what has been seen to date for Ab-peptide
complexes. A comparison between PC283 structure and a homology model of its germline ancestor suggests that paratope opti-
mization for PS1 occurs by improving both charge and shape complementarity. The Journal of Immunology, 2000, 165: 6949–
6955.
T hree-dimensional structures of a variety of Fab-Ag com-plexes have provided fine details of Ag-Fab recognition(1–3). Yet there is a lack of a unified structural model for
explaining various subtle details of specificity and diversity (3).
This is principally because each Ag-Ab complex is unique with
respect to the binding site, although the variation in overall Ab
structure is less compared with that of other proteins. Differences
in the length and the nature of key residues of the complementa-
rity-determining regions (CDRs)3 contribute to varied topologies
within the paratope (3). The wide diversity in Ag binding speci-
ficities is largely attributed to this variation in the surface features
of the CDRs. The structural repertoire of CDRs does not encom-
pass an infinite number of main chain conformations. Instead, a
finite number of them appear to be used (4–6). Thus, only a lim-
ited backbone conformational repertoire in the CDRs accounts for
the diversity of humoral recognition. Indeed, the nature and con-
formation of the amino acid side chains provide yet another level
of diversity.
Among the myriad of Ags, synthetic peptides have proved to be
useful model systems for the study of humoral responses. One such
peptide Ag, PS1CT3, which includes a B cell epitope (segment PS1,
sequence HQLDPAFGANSTNPD) derived from the large envelope
protein of the hepatitis B virus and a promiscuous T cell epitope
(segment CT3, sequence DIEKKIAKMEKASSVFNVVNS) (7) led
to the elucidation of a variety of cellular mechanisms that guide in-
duction and progression of T-dependent humoral responses (8, 9). A
large panel of genetically distinct murine mAbs was derived from a
secondary response to the peptide (7). Intriguingly, although they
were derived from diverse B cell precursors, all mAbs recognized a
common epitope (DPAF) within the PS1 sequence with comparable
affinities (10). Thus, it can be expected that an analysis of binding of
an epitope to genetically diverse Abs will provide important addi-
tional information on the nature of Ag recognition in humoral
responses.
The present report details the results of our first step in this
direction. We describe the crystal structure of the Fab of an IgG1k
murine mAb, PC283 (7), bound to peptide PS1. The Ab and its Fab
bind to PS1 with association constants (Ka) of 2.5 3 106 and
1.02 3 106 M21, respectively, as determined using IAsys affinity
biosensor (our unpublished observations). This structure provides
interesting new insights concerning Ag-Ab recognition. These in-
clude preponderance of the light chain contacts with Ag, involve-
ment of a distal framework residue in binding, and the fact that a
segment of the peptide is partly raised above the binding site.
Further, a comparison of the structure of mature Ab PC283 with
a homology model of its germline ancestor indicates improvement
of charge and shape complementarity during maturation of
T-dependent humoral response against PS1.
Materials and Methods
Preparation of PC283 Fab
The Ig was precipitated from ascitic fluid with 40% ammonium sulfate.
The IgG was purified from this precipitate by ion exchange chromatogra-
phy using a salt gradient. The IgG was then cleaved to obtain Fab using
papain (Sigma, St. Louis, MO) (11). Fab molecules were purified from the
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digestion mixture again by ion exchange chromatography using a salt gra-
dient. The Fab fractions were processed to obtain a final concentration of
10 mg/ml in the crystallization buffer.
Crystallization
A number of precipitants at different concentrations were explored to crys-
tallize the PC283 Fab-PS1 complex using the hanging drop vapor diffusion
method. The crystals were obtained using a starting Fab concentration of
10 mg/ml (with a 20-fold molar excess of peptide) from the solution of 50
mM Tris-Cl, pH 7.2, after equilibrating with 18% polyethylene glycol
(3.3 kDa).
Data collection
The x-ray intensity data were collected on Image Plate (Marresearch, Norder-
stedt, Germany) installed on a rotating anode x-ray source (RIGAKU) oper-
ated at 40 kV and 70 mA (CuKa radiation) with a nickel monochromator. The
crystals diffracted up to 2.9 Å resolution and were suitable for structural stud-
ies. The crystal data and the intensity statistics are shown in Table I. It was
inferred from calculations of the Matthews constant (Vm) (12) that there is only
one Fab molecule in the asymmetric unit. The solvent content was calculated
to be 43%. The intensity data were processed using DENZO (13).
Structure determination
BLAST (14) was used to search for Fab molecules in the PDB (15) that
have sequence homology with PC283 for both chains. This revealed that
the anti-hapten (2,2,6,6-tetramethyl 1-piperidinyloxy 2-dinitrophenyl) Fab
molecule 1BAF (16) shows maximum sequence homology with PC283
(86%). Molecular replacement was conducted with 1BAF as the probe
model using AMoRe (17). 1BAF gave a good correlation coefficient
(32.1%) and R factor (45%), and subsequent refinement was conducted
using this model.
Refinement
Further refinement was conducted using X-PLOR (18). Both conventional
crystallographic R factor (Rcryst) and free R factor (Rfree) (19) values (7%
of total reflections) were used to monitor refinement progress. Initial rigid
body refinement using whole Fab gave Rcryst and Rfree of 46.8 and 46.9%
respectively. On defining VH, VL, CH, and CL domains as discrete units, the
rigid body refinement led to Rcryst and Rfree of 33.8 and 35.1%, respec-
tively. The model was further refined by the positional refinement protocol
of X-PLOR. Electron density maps were displayed with the help of pro-
gram O (20) on INDIGO (2) (Silicon Graphics, Mountain View, CA) and
the sequence of 1BAF was slowly changed to that of PC283 during iter-
ative refinement. In PC283, CDRs L1 and H3 have a single residue inser-
tion each, and CDR L3 has a two-residue-long deletion with respect to
1BAF. However, the CDRs were not removed completely from the search
model. The side chains and backbone conformations of the CDR loops
were rebuilt iteratively as the density in these regions improved. After all
the changes were made, and the hypervariable loops had been rebuilt, clear
and empty density could be seen in the Ag binding site into which the
peptide PS1 was gradually built. Initially, the stretch DPAF could be un-
ambiguously fitted into the electron density, and the rest of the peptide
could be built subsequently as the refinement progressed. Once the entire
peptide model was built into the density, water molecules were added using
the water-pick program in Crystallography and NMR System (21). All
atoms were refined with group anisotropic B factors and were within rea-
sonable limits. The current model has an Rcryst of 18.8% and an Rfree of
26.1% using all data between 100 and 2.9 Å. The overall quality of the
model was checked with PROCHECK (22). The solvent accessible area
was calculated using the ACCESS-SURF module of MSI software (Mo-
lecular Simulations, San Diego, CA) based on the Lee-Richards algorithm
(23) using a probe radius of 1.4 Å. The intrapeptide and Ab-peptide con-
tacts were determined using XPLOR.
Model building
The model for the germline sequence was built using the HOMOLOGY
module of the MSI software. The available germline sequence was aligned
with that of the mature PC283 (Fig. 1), and the model of the germline Ab
Fab was built using the coordinates of the PC283 as template. This was
followed by conjugate gradient minimization of the model to remove short
contacts using the DISCOVER module in which all atoms of the hyper-
variable loops and the side chains of the rest of the residues were allowed
to move. This was followed by 50-ps molecular dynamics simulation at
300°K, in which the rest of the molecule, except for the hypervariable
loops, was restrained. During the molecular dynamics simulation, confor-
mations were written out after every 5 ps. These conformations were fur-
ther subjected to conjugate gradient minimization until convergence. Dis-
tance dependent dielectric constant and consistent valence force field were
used for all the energy-based computations. All energies were measured
using INSIGHTII. The geometry of the least energy conformation was
assessed using PROCHECK. The peptide from the PS1-PC283 crystal
Table I. Crystal data and refinement statisticsa
Space group P212121
Cell constants a 5 69.298 Å, b 5 72.825 Å, c 5 84.783 Å
Maximum resolution 2.9 Å
Total observations 11,134
Unique reflections 7953
Rmerge (%) 12.4 (33.3)
Completeness (%) 82 (61.1)
Multiplicity 1.4
Average (I)/(SigI) 5.1 (2.1)
No. of protein
atoms3252
No. of peptide atoms 111
No. of solvent atoms 37
Rcrys (%) 18.8 (27.2)
Rfree (%) 26.1 (37.5)
Refinement range (Å) 100 22.9
rmsd bond length (Å) 0.007
rmsd bond angles (°) 1.571
Ramachandran plot 81.2% residues in core regions, 16.8%
residues in allowed regions, 2% residues
in generously allowed regions.
Average B value of
PC283 atoms (Å2)
24.166
Average B value of
PS1 atoms (Å2)
65.254
a The corresponding data for the last shell (2.90-3.03) are given in parentheses.
FIGURE 1. Alignment of germline and PC283 sequences. The differ-
ences are highlighted by an asterisk under the dissimilar residues. The
CDRs are also highlighted in bold lettering, and their numbers are written
above the sequences. The residues of PC283 which interact with the pep-
tide are underlined.
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structure was docked on the final germline model by least square super-
imposition of the Fv domains. The intermolecular energies between peptide
and Ab were calculated using the DOCKING module of MSI software.
Results
PC283 Fab structure and the conformation of the bound PS1
peptide
The final model of the PC283-PS1 complex was built on the basis
of a 2.9 Å resolution electron density map. The structure of the
PC283 Fab has four standard Ig folds, two each for the light chain
(VL and CL) and the heavy chain (VH and CH). The available
sequence of PC283 was used for model building (24). Most of the
PC283 Fab structure was unambiguously modeled into good elec-
tron density, although there were a few regions showing poor den-
sity. The longest stretch showing poor electron density was an
exposed loop from Leu132H to Asn137H, a region that appears to
be disordered in most Fab structures (25). There were also a few
solvent-exposed side chains that were not observed throughout the
refinement, and these residues were all modeled as alanine. During
refinement, the residue Ala51L consistently showed disallowed di-
hedral angles. Residues at this position have been observed in
other Fab structures to possess disallowed dihedral angles (26).
The elbow angle of PC283 Fab was calculated to be 147o, which
is within the range known to date (127–227o) for Fab molecules.
It is about 10o less than that of the search model 1BAF (156o).
The 2Fo-Fc map of the peptide (Fig. 2A) indicated that the den-
sity for the peptide was clearly defined. The stretch Leu3P to
Ala9P showed strong electron density. The terminal residues
His1P and Gln2P and two of the residues propped up from the Ag
combining site, Asn10P and Ser11P, showed relatively weak elec-
tron density. The stereoscopic drawing of the peptide is shown in
Fig. 2B. The conformation of the peptide shows two consecutive
b-turns formed by His1-Gln2-Leu3-Asp4 and Asp4-Pro5-Ala6-
Phe7 covering the first seven residues of the peptide. The peptide
shows presence of two intrapeptide hydrogen bonds between
His1P and Asp4P and between Asp4P and Phe7P (Table III) cor-
responding to these two consecutive b-turns. The His1P side chain
is raised above the binding site, so that only the backbone atoms
show contacts with the hypervariable loops. The stretch Gln2P to
Phe7P is present in the binding site, while the next three residues
of the peptide are raised above the Ag binding groove. The resi-
dues Ser11P, Thr12P, and Asn13P then loop back onto the surface
of the Ab. The last two residues, Pro14P and Asp15P, extend out-
side the binding site without any contacts. The looped up confor-
mation of PS1 is evident in Fig. 3, which shows the side view of
the interaction of the peptide with the Ab.
PC283 Fab-PS1 interaction
The peptide binding site is formed at the junction of light and
heavy chains such that PS1 sits in a groove and is surrounded by
all six CDR loops. The base and sides are formed by the residues
Ala25L (L1), Val29L to Ser34L (L1), Ile47L to Gly49L (L2), and
Tyr91L to Pro94L (L3) of the light chain and Ala34H (H1),
Asn36H (H1), Tyr51H (H2), Arg53H (H2), and Gly99H to
Phe103H (H3) of the heavy chain. The residues, which directly
interact with the peptide, are shown in Fig. 4A (27). The CDRs H1,
L2, H2, L1, H3, and L3 (in increasing order of number of inter-
actions) together form all the 188 contacts with the peptide. The
contacts constitute 181 van der Waals contacts, six hydrogen
bonds, and one salt bridge (Tables II and III). CDRs L2 and H1
show very few interactions with the peptide. The light chain
CDRs, L1 and L3, and the heavy chain CDR, H3, contribute most
of the van der Waals contacts: 27, 75, and 50, respectively. Most
of the contacts (130 of 188) are with the side chains of the peptide,
an observation consistent with other Ab-peptide complexes (3).
Both the van der Waals contacts (Table II) and the hydrogen bond-
ing interactions (Table III) between PS1 and PC283 are listed.
Most of the contacts of peptide with Ab are through the five
residues, Leu3-Asp4-Pro5-Ala6-Phe7, of PS1. This is reflected in
the average B factors of all atoms of this stretch (27 Å2), which is
much lower than the average B factors for all atoms of the entire
peptide (65 Å2). The Leu3P fits snugly into a hydrophobic groove,
Asp4P forms a salt bridge with Arg53H, and Phe7P is present in
a hydrophobic cup formed by the hypervariable loop residues. The
FIGURE 2. Structure of the peptide PS1. A, The stereoscopic drawing
of the 2Fo-Fc electron density map of the peptide. The electron density is
defined at the contour level of 0.8s. B, The stereoscopic drawing of the PS1
peptide showing the two intrapeptide hydrogen bonds in the form of thin
lines.
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residues Pro5P and Ala6P also form a number of van der Waals
interactions with the CDR residues. As shown in Table II, the
residue stretch Ser11-Thr12-Asn13 of the peptide also forms a
significant number of contacts with the Ab. While most of these
contacts are with the CDR L3, the residue Asn13P also shows a
significant number of interactions with the framework residue
Asp1L. The side chain of the Asn13P residue is present above the
residue Asp1L, as a result of which there are eight van der Waals
contacts between the two residues. Only the side chain atoms of
Asn13P are involved in this interaction, but in the case of Asp1L,
both the side chain and the main chain atoms show contacts.
Among the other residues, His1P interacts only through its main
chain atoms, whereas the residues Gly8P, Ala9P, Asn10P, Pro14P,
and Asp15P do not show any interactions with Ab.
The Ag binding groove is predominantly hydrophobic, with hy-
drophilic patches formed by Glu27L, Asn53L, and Arg53H (Fig.
4B). There are a number of aromatic amino acids present in the
groove. The molecular surface area buried upon PS1 binding is
756 Å2 for the peptide and 625 Å2 for the Fab. This corresponds
to about 45% of the peptide molecular surface being buried upon
PS1 binding. Of the total buried molecular surface area of the Ab,
37% is from residues in the heavy chain, while the other 63% is
from residues in the light chain. The percentages of accessible
surface area of the framework residues, Asp1L and Ile2L, buried
due to the peptide binding are 15 and 40%, respectively. For the
individual peptide Ag residues, .95% of the solvent-accessible
surface area of Leu3P and Phe7P is buried upon binding to PC283.
Further, .75% of Asn13P is buried on binding. Thus, most of the
surface area of the residues Leu3P, Phe7P, and Asn14P is buried.
This is consistent with the fact that these residues collectively con-
stitute the bulk of the contacts with Ab.
Model of the germline Ab and comparison with PC283 structure
The sequence of the germline progenitor of PC283 Ab is known
(24). Compared with this, light chain of PC283 shows two
changes, whereas the heavy chain shows a total of 13 changes in
the sequence. The alignment of germline and PC283 sequences
highlighting these changes is shown in Fig. 1. Among the inter-
acting residues in the PS1-PC283 complex, those that have ap-
peared through somatic mutation are Ala34H, Arg53H, Thr101H,
and Gly102H in place of Tyr, Ser, Asp, and Trp, respectively.
A homology model of the germline Ab Fab was built using
coordinates of PC283 as the template. The Ramchandran map
showed that about 98% of the total number of residues are present
in the allowed regions. The root-mean-square deviation (rmsd) be-
tween all the Ca atoms of the germline model and the Fv region of
the PC283 structure was calculated to be 0.7 Å. The rmsd values
for Ca atoms of all the CDR residues was 1.3 Å, with those of L3
(1.41 Å), H2 (2.1 Å), and H3 (1.3 Å) being significant. In the
germline model, it is seen that the volume of the peptide binding
groove is significantly lower due to the presence of Tyr in place of
Ala34H, and Trp in place of Gly102H. Also, accommodation of
the bulky Trp102H side chain requires the CDR H3 to move out-
ward, away from the center of the groove. The conformations of
CDRs L3 and H2 are different from those in Ab PC283 to a large
extent to accommodate the bulky residue Trp102H of CDR H3 and
the three mutations within H2, respectively. The remaining CDRs,
L1, L2, and H1, do not show significant change in their main chain
conformation. The change Ser53H to Arg is very significant, since
it is observed that Arg53H in the mature Ab forms a salt bridge
with Asp4P, which in terms of individual interactions provides
maximum stability to the bound peptide.
Fig. 4C shows the surface representation of the paratope in the
germline model with the peptide displayed in the same conforma-
tion as that seen in the PC283-PS1 complex. The intermolecular
energy between peptide and germline Ab model was calculated to
be 3 3 109 kcal/mol, which is much higher than the corresponding
energy (2130 kcal/mol) between the peptide and PC283 in crystal
structure. The residues Leu3P, Pro5P, Ala6P, and Phe7P show
large number of short contacts with Ab residues. The residues
Ser11P, Thr12P, and Asn13P also show very high number of short
contacts.
FIGURE 3. Stereoscopic model of the PC283-PS1 complex. The peptide PS1 is shown as a thick stick, and the variable domains of the PC283 Fab are
shown in ribbon representation.
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Discussion
Peptide PS1 adopts a definite three-dimensional structure on bind-
ing to Ab PC283, with two intrapeptide hydrogen bonds contrib-
uting to two consecutive b-turns. In contrast, it has been previ-
ously observed that this peptide does not show a well-defined
conformation in solution (10). The conformation of bound peptide
following the b-turns is also unusual. The stretch Gly8P-Ala9P-
Asn10P is raised above the binding site and forms a loop, display-
ing no interactions with the protein. These three residues are com-
pletely solvent accessible. The next three residues, Ser11-Thr12-
Asn13, are present close to the paratope and form a large number
of contacts with residues of the light chain. The presence of such
centrally placed noninteracting residues in a peptide bound to an
Ab is rare (25, 28).
Binding of PS1 to PC283 occurs through two nonoverlapping
interaction sites. The site of primary interaction with the Ab is
FIGURE 4. The Ag binding site of
PC283. A, The stereoscopic drawing
showing the residues of PC283 that are
involved in direct contacts with the
peptide PS1. The Ab residues are col-
ored light cyan, and the peptide is
shown in standard element colors. B,
Structural features of the PC283-PS1
complex. The Connolly surface (27) of
PC283 is decorated with the hydropa-
thy feature with a color spectrum in
which red to blue stands for hydropho-
bic to charged, respectively. The pep-
tide residues are shown in sticks. C,
Structural features of the germline Ab-
PS1 complex. The peptide Ag (shown
in sticks) is superimposed on the Con-
nolly surface (27) of the germline
PC283 model shown in light cyan. The
interacting residues that are different in
germline Ab compared with the ma-
tured PC283 are highlighted in light
magenta.
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incorporated within the first seven residues of the peptide. It is
evident from the crystal structure that peptide PS1 is stabilized on
the paratope primarily through interactions of the stretch Leu3-
Asp4-Pro5-Ala6-Phe7 with the Ab hypervariable residues. This is
also consistent with the earlier findings on localizing the epitope
for PC283 based on screening against overlapping PS1-derived
synthetic hexapeptides (7). The residues Pro5P and Ala6P do not
show as many or as strong interactions with the Ab as the other
residues Leu3P, Asp4P, and Phe7P. However, they might serve to
space and orient the peptide such that the side chain of Asp4P
forms a salt bridge and that of Phe7P is inserted into the hydro-
phobic cup. Thus, a combination of van der Waals contacts and
hydrogen bonds, within the peptide and with the Ab, orient and
anchor the residues Leu3-Asp4-Pro5-Ala6-Phe7 of PS1 in the
PC283 Ag binding site. It is appropriate to mention here that the
Leu3-Asp4-Pro5-Ala6-Phe7 region of the peptide represents an
immunodominant epitope recognized by PC283 as well as a series
of other genetically independent mAbs raised against PS1 (7).
The residues Ser11-Thr12-Asn13 of the peptide constitute the
secondary interaction site. The PC283 Fab interacts with this re-
gion primarily through the light chain CDR L3. In addition, a
significant number of contacts with Asp1L, a residue belonging to
the framework region, are observed. While there are other in-
stances where framework residues have been implicated in Ag
binding, these were all located proximal to the CDR residues (29,
30). The present structure must be the first case where a framework
residue distal to the CDRs forms a significant number of interac-
tions with the peptide. The involvement of such a contact in pep-
tide recognition by germline Ab may be expected to contribute to
the affinity of binding, thereby promoting selection of the corre-
sponding B cell clonotype from the preimmune pool (31).
Table III. PC283-PS1 residues involved in hydrogen bonding
Atom 1 Atom 2 Distance (Å)
Intrapeptide
His1P: -O Asp4P: -N 3.60
AsprP: -O Phe7P: -N 3.50
Fab-peptide
Tyr32L: -OH His1P: -N 2.81
Tyr49L: -OH Gln2P:-NE2 3.40
Thr91L: -O Ala6P: -N 3.25
Ser93L: -OG Ser11P: -OG 3.34
Tyr94L: -OH Thr12P: -OG1 3.09
Arg53H: -NH2 Asp4P:-OD2 3.09
Tyr51H: -OH Phe7P: -O 2.67
Table IV. Structural features of Ab-peptide complexesa
PDB
Code Ag
Solvent-Asccesible
Surface Areab
L H Peptide Conformation
1A3R VKAETRLNPDLQPTE-NH2 45.9 54.1 g turn, type 1b turn, Asn pseudoturn, 310 helix
1ACY YNKRKRIHIGPGRAFYTTKNIIGC 23.6 76.4 Type II b-turn followed by type III b-turn, III-1 bend
1AI1 YNKRKRIHIGPGR (Aib) FYTTKNIIGC 46.1 53.9 Same as 1ACY
1BOG GATPEDLNQKLAGN 41.4 58.6 Extended with 2 bends
1CE1 Ac-TSSPSAD 45.5 54.5 Extended
1CFN GATPQDLNT (norL) 36.8 63.2 Extended with 2 bends
1CFS GLYEWGGARITNTD 48.4 51.6 Wide bend
1CFT EfslkGpllqwrsG 48.9 51.1 Extended
1CU4 KPKTNMKHMA 33.6 66.4 v turn
1F58 YNKRKRIHIGPGR (Aib) FYTTKNIIGC 47.2 52.8 Type I turn, followed by type VIa turn and type I turn
1FPT CVTIMTVDNPASTTNKDK 29.5 70.5 S-shaped with two b-turns
1FRG Ac-DVPDYASL-amide 32.8 67.2 b-turn
1GGI CKRIHIGPGRAFYTTC 38.4 61.6 Turn
1HIM YDVPDYASL-amide 22.4 77.6 Type 1 b-turn
1SM3 TSAPDTRPAPGST 31.2 68.8 Extended
1TET VEVPGSQHIDSQKKA 47.4 52.6 b-turn
2F58 JHIGPGRAFGZG-amide 44.9 55.1 Same as 1F58
2HIP GLQYTPSWMLVG 51.1 48.9 b-turn, inverse g turn
2HRP MSLPGRWKPK 50.1 49.9 b-turn
2AP2 VVQEALDKAREGRT 42.8 57.2 Ampipathic 3.5 turn helix
2MPA Ac-(Thc) KDTNNNLC*-amide 38.3 61.7 b-turn
3F58 JSIGPGRAFGZG-amide 45 55 Same as IF58
2IGF EVVPHKKMHKDFLEKI 20 80 type II b-turn
PC283 HQLDPAFGANSTNPD 62.6 37.4 Two consecutive b-turns
a The peptide residues for which electron density is defined are in bold and those showing interactions with the Ab are underlined.
b The percentage of total loss in solvent accessible surface area of Ab on peptide binding.
Table II. PC283-PS1 residues involved in van der Waals contacts
Fab Residue CDR Peptide Residue
Heavy chain
Ala34H H1 Phe7P
Asn36H H1 Phe7P
Tyr51H H2 Phe7P; Ala6P
Arg53H H2 Asp4P; Phe7P
Gly99H H3 Phe7P
Gly100H H3 Phe7P; Leu3P; Asp2P
Thr101H H3 Gln2P; Leu3P
Gly102H H3 Leu3P
Phe103H H3 Phe7P
Light Chain
Glu27L L1 Asn13P
Tyr32L L1 Pro5P; His1P;Leu3P
Tyr49L L2 Gln2P; Leu3P
Gly50L L2 Leu3P
Asn53L L2 Gln2P
Thr91L L3 Leu3P; Pro5P; Ala6P; Phe7P
Tyr92L L3 Pro5P; Ser11P; Ala6P
Ser93L L3 Ser11P; Thr12P;Asn13P; Ala6P
Tyr94L L3 Thr12P; Asn13P
Pro95L L3 Ala6P
Asp1L Framework Asn13P
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The PC283-PS1 complex is among the few examples where the
light chain CDRs show more interactions than the heavy chain
CDRs. This is contrary to the trend seen to date, with the heavy
chain CDRs being more involved in forming contacts in the case
of most other peptide-Ab complexes (3). The amount of the buried
surface area of the peptide is much higher than the average surface
area buried in similar cases (464–576 Å2), observed until now
(26). This is true also in case of the Ab (413–523 Å2) (26). Various
structural features of the PC283-PS1 complex were compared with
those of other Ab-peptide complexes in the PDB (Table IV). In
most cases the interacting residues of the peptide form a continu-
ous stretch regardless of the peptide conformation. Among the few
complexes that show a discontinuous epitope, PS1 has the longest
stretch of noninteracting residues that are sandwiched between the
primary and secondary interaction sites. The percent contributions
to the total decrease in accessible surface area of the heavy and
light chains on peptide binding for all the structures are listed in
Table IV. It is clear that the percent contribution to the total de-
crease in accessible surface area of light chain in PC283-PS1 is
much more than that seen for the other structures (15% more than
the next highest one). Correspondingly, PC283 shows more con-
tacts with the peptide through the light chain compared with the
other anti-peptide Abs. Thus, PC283 shows an exceptionally high
use of the light chain for Ag binding.
A comparison of a model of the germline progenitor with the
PC283 structure could shed light on the structural basis of the
changes in paratope during maturation of the PC283 Ab. Interest-
ingly, most of the somatic mutations are in the heavy chain even
though the light chain shows more contacts with the Ag in the case
of mature Ab. The mutation of Ser53H to Arg leads to the forma-
tion of a salt bridge, with Asp4P enhancing the charge comple-
mentarity and thereby providing critical electrostatic stability in
the Ag-Ab interaction. The binding affinity is also improved by
decreasing the possibility of steric clashes, and this is achieved by
mutating bulky aromatic residues (Trp102H and Tyr34H) into
smaller side chains. These mutations may optimize the shape
complementarity between the peptide and the Ab. Thus, it is clear
that the mutations lead to an overall increase in complementarity
for the immunodominant epitope Leu3-Asp4-Pro5-Ala6-Phe7.
Since in the germline model the paratope appears to be dissimilar
from that in the mature Ab, it is likely that the conformation of the
peptide when bound to the germline Ab will be different from that
seen in the crystal structure.
In summary, the structure of the PC283 complex reveals novel
features adding to our understanding of Ag-Ab recognition. It is
particularly intriguing that optimum somatic mutations occur pri-
marily in the heavy chain CDRs, although the contacts with the
epitope are predominantly through the light chain CDRs. Also no-
table is the observed involvement of a distal framework residue in
establishing significant contacts with the bound Ag. Finally, our
analysis indicates that the affinity maturation of PC283 occurs
through optimization of critical charge interactions in addition to
removal of steric clashes.
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